Homeland Security and U.S. Customs face a daunting task in policing the millions of packages full of textile fabrics and apparel that come into the country duty free. They know it. What can be done about it, is the question.
In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
A recent study suggests that Americans prefer locally produced medications if they are unclear where the product was made or if the lab has received bad reviews from an FDA inspection.
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has
Last year, more than 73,000 Americans died from an overdose of the synthetic opioid fentanyl. The drug itself is cheap and readily available, with thousands of pounds flowing into
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines
The following written testimony was submitted by Michael Stumo, CEO of CPA, to the House Homeland Security Subcommittee on Oversight, Investigations, and Accountability in a
The U.S. China Economic & Security Review Commission heard from witnesses about keeping auto tariffs on China, and more incentives for manufacturing to reshore.